What Ketoprofene EG treats: main uses and benefits

Ketoprofene EG is a medicinal product belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used to manage symptoms associated with inflammatory, painful, and degenerative conditions affecting the musculoskeletal system.

Therapeutic Indications

This medication is indicated for the symptomatic treatment of various conditions that cause pain and inflammation in the joints, muscles, and bones. The primary areas of application include:

• Rheumatoid Arthritis: A chronic inflammatory disorder affecting the joints.
• Osteoarthritis: A degenerative joint disease that causes the breakdown of cartilage.
• Ankylosing Spondylitis: A type of arthritis that primarily affects the spine.
• Acute Articular Rheumatism: Relief of pain and inflammation during acute flare-ups of rheumatic conditions.
• Extra-articular Rheumatism: This includes conditions such as bursitis, tendinitis, and synovitis, where inflammation occurs in the tissues surrounding the joints.

Management of Acute Pain

In addition to chronic conditions, Ketoprofene EG is utilized for the short-term management of acute painful episodes, such as:

• Post-traumatic Pain: Relief of pain resulting from injuries, sprains, or strains.
• Post-operative Pain: Management of discomfort following surgical procedures.
• Lumbago and Sciatica: Treatment of acute lower back pain and nerve-related pain.

Benefits and Action

The primary benefit of Ketoprofene EG lies in its ability to inhibit the production of prostaglandins, which are chemicals in the body that signal pain and trigger inflammation. By reducing these substances, the medication helps to:

• Diminish joint swelling and stiffness.
• Improve physical mobility and functional capacity in patients with chronic joint diseases.
• Provide relief from localized or systemic pain associated with inflammatory processes.

Regulatory References

1. NIH LiverTox overview

Official Eligibility Rules for Ketoprofene EG (Ketoprofen)

Ketoprofene EG use is determined by official regulatory criteria, primarily based on contraindications, age, and existing health conditions.

Contraindicated Populations

The medicine is strictly contraindicated and must not be used by patients with a known hypersensitivity to ketoprofen or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including those who experience aspirin-induced asthma or urticaria. Use is prohibited for patients with an active peptic ulcer or a history of recurrent gastrointestinal bleeding, perforation, or ulceration. It is also contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and during the third trimester of pregnancy.

Age and Condition-Based Restrictions

Safety and efficacy are generally not established for use in the pediatric population. Older adults may use the medicine but require caution due to an increased risk of serious adverse events. Use is restricted for patients with impaired renal function (with severe impairment being a contraindication) and those with impaired hepatic function; in these groups, use requires careful monitoring. During the first and second trimesters of pregnancy, use should be avoided unless medically necessary, and it is not recommended for breastfeeding women.

Interactions with other medicines and products

This section outlines interactions for Ketoprofene EG (Ketoprofen) as documented in official government regulatory labels. These interactions are classified based on the risk of altered drug exposure or enhanced adverse pharmacodynamic effects.

Contraindicated and High-Risk Combinations

Co-administration of Ketoprofene EG is contraindicated with certain medicines and clinical contexts due to severe risk:

• High-Dose Methotrexate (15 mg/week or greater): Prohibited due to the risk of increased Methotrexate plasma concentrations and toxicity resulting from reduced renal clearance.
• Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors: Contraindicated due to an additive risk of serious gastrointestinal (GI) adverse effects, such as bleeding or perforation.
• Perioperative Pain following coronary artery bypass graft (CABG) surgery is a prohibited use.

Clinically Significant Interactions

Interactions that require monitoring or caution are based on either pharmacokinetic (PK) or pharmacodynamic (PD) effects:

• Anticoagulants (e.g., Warfarin, Heparin) and SSRIs: Increased risk of bleeding due to additive effects on hemostasis and potential GI irritation.
• Diuretics and Antihypertensives (e.g., ACE Inhibitors, ARBs): Co-administration may reduce the efficacy of these medicines and increase the risk of acute renal dysfunction.
• Lithium: NSAIDs may cause an elevation of plasma Lithium levels due to reduced renal clearance.
• Probenecid: Significantly increases Ketoprofen plasma concentrations due to reduced renal clearance, and this combination is generally not recommended.
• Food: Administration with food reduces the rate of absorption ( Cmax is lower and Tmax is delayed), but does not typically alter the total amount absorbed ( AUC).

Note: The risk of interaction-related adverse reactions, particularly GI and renal events, is heightened in the elderly population.

How Ketoprofene EG Works

The action of Ketoprofene EG is defined by its ability to inhibit key enzymatic pathways involved in generating inflammatory and pain signals, resulting in the modulation of physiological responses.

---

Dual Inhibition of Pro-Inflammatory Enzyme Pathways (COX and LOX)

Ketoprofen acts as a reversible inhibitor that targets both Cyclooxygenase (COX) enzymes (COX-1 and COX-2) and the Lipoxygenase (LOX) pathway. By blocking these key steps in the Arachidonic Acid Cascade, the drug suppresses the synthesis of major inflammatory mediators, including prostaglandins and leukotrienes. This core mechanism supports reducing the magnitude of inflammatory pathway activation by reducing the influence of mediators associated with tissue fluid accumulation and nociceptor sensitization.

---

Integrated Central and Peripheral Pain Signaling Modulation

Ketoprofen modulates nociception through a dual action. Peripherally, the reduction of Prostaglandin E2 prevents the sensitization of nociceptors (pain-sensing nerve endings). Centrally, Ketoprofen engages mechanisms within the brain and spinal cord, including pathways involving the serotonergic system, which controls the descending transmission of pain signals. This combined approach results in the suppression of pain signal initiation and processing.

---

Central Thermoregulation Adjustment

Ketoprofen exerts a direct effect on the hypothalamus, the brain's control center for core body temperature, distinct from its peripheral actions. The mechanism involves reducing the synthesis of PGE2 specifically in this area. This molecular adjustment restores the thermal set-point to physiological levels, triggering the mechanism for temperature regulation.

Administration and Usage

Ketoprofene EG is available in various formulations, including oral forms such as capsules or tablets, and topical forms like gels. The method of administration depends entirely on the specific pharmaceutical form prescribed.

Oral Administration

When taking oral forms of this medication, it is generally recommended to take the dose during or immediately after a meal. This approach is intended to manage the interaction between the medication and the gastrointestinal lining. Tablets or capsules should be swallowed whole with a sufficient amount of water.

Topical Administration

For topical applications, the gel is applied directly to the skin over the affected area. It is typically spread with a gentle massage to facilitate local absorption. Following application, it is important to wash hands thoroughly to avoid accidental contact with sensitive areas, such as the eyes or mucosal membranes.

General Considerations for Use

To maintain a consistent level of the active substance in the body, it is helpful to use the medication at the same times each day. The duration of use is determined based on the nature of the condition being addressed and the individual response to the product. If the medication is being used for a chronic condition, periodic evaluations may be conducted to monitor the ongoing necessity of the application.

Research Evidence / Overview of Studies for Ketoprofene EG

This section provides a descriptive overview of the existing scientific literature and regulatory findings for Ketoprofene EG, focusing only on how the medication was studied and what was observed. This research provides context but not individual predictions.

---

Evidence for use in Chronic Joint Conditions (Rheumatoid Arthritis and Osteoarthritis)

Research has examined the use of oral and topical Ketoprofene EG in conditions characterized by functional limitations such as rheumatoid arthritis (RA) and osteoarthritis (OA). The evidence is primarily derived from short- to intermediate-term Randomized Controlled Trials (RCTs) and systematic reviews where Ketoprofene EG was included for evaluation alongside placebo or other substances. These studies typically monitored outcomes related to physical discomfort and daily functioning in adult populations. Trials reported the measured variations between groups receiving Ketoprofene EG and those receiving an inactive placebo. The available data is primarily based on follow-up durations that were limited, and the evidence is often insufficient to fully establish long-term effects or the sustainability of the measured changes.

---

Evidence for use in Acute Pain and Soft Tissue Injuries

Ketoprofene EG was evaluated in research exploring its use for conditions associated with acute or disruptive episodes, such as pain after minor surgical procedures or localized pain from sprains and tendinitis. The evidence is derived from single-dose RCTs or very short-course comparative trials. Primary outcomes that were observed in these trials included the measurement of the time of pain relief onset and the overall change in pain scores. Trial reports consistently described that the measurements of pain scores varied between the groups receiving Ketoprofene EG and those receiving the placebo in the hours following a single dose. Because the follow-up durations were limited, the evidence provides limited insight into outcomes for managing acute pain episodes that extend beyond seven days.

---

Evidence Gaps and Areas of Scientific Uncertainty

The research on Ketoprofene EG highlights what is known—and what is still uncertain. The long-term effects are not fully established regarding the use of the medication over many months or years. Evidence quality varies across studies, and findings from certain smaller or older trials may be limited in their applicability today. Subgroup findings are uncertain, meaning there is limited detailed data on patients with different disease severities or specific co-existing conditions. Research provides context but not individual predictions.

Key Studies & References

1. Efficacy and safety of over-the-counter analgesics for primary dysmenorrhea - A network meta-analysis
2. Label: KETOPROFEN capsule - DailyMed (FDA-supported labeling for oral use)

Common questions about Ketoprofene EG (FAQ)

Q: Is Ketoprofene EG the same as other medicines for pain relief?

A: According to official documents, Ketoprofene EG is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Its active ingredient, Ketoprofen, is chemically related to other medicines in the arylpropionic acid group, such as ibuprofen. Its classification indicates it works similarly to other pain relievers in the same group.

Q: How quickly does Ketoprofene EG start working?

A: Studies on the immediate-release oral form show that when taken while fasting, the peak concentration in the blood is typically reached within 0.5 to 2 hours. This measurement reflects the typical speed at which the active ingredient is absorbed into the bloodstream.

Q: Can Ketoprofene EG be used for period pain?

A: Official regulatory documents list specific uses for the oral form. According to the official product information, Ketoprofene EG is indicated for the treatment of menstrual cramps (primary dysmenorrhea) in adults.

Q: Is Ketoprofene EG suitable for headaches?

A: Regulatory indications state that Ketoprofen is used for the relief of mild to moderate pain. Specific formulations are cited for use in conditions including headache.

Q: What is the main difference between Ketoprofene EG and Ibuprofen?

A: Both medicines belong to the same class of NSAIDs (Nonsteroidal Anti-inflammatory Drugs) and share similar analgesic and anti-inflammatory effects. The active ingredient in Ketoprofene EG, Ketoprofen, is part of the arylpropionic acid chemical group, which is the same classification as Ibuprofen.

Q: Can Ketoprofene EG make you feel drowsy or sleepy?

A: Regulatory documents list drowsiness and sleepiness as potential adverse effects. These are symptoms that have been documented in official labeling, including reports related to possible overdose.

Q: What medical conditions must I tell my doctor about before taking Ketoprofene EG?

A: Official documents provide important warnings regarding existing medical history. This includes existing conditions such as heart problems, high blood pressure, heart failure, or impaired kidney function.

Q: Does the time of day matter when taking Ketoprofene EG?

A: The oral forms have specific administration schedules, such as once daily or divided doses, based on whether they are immediate-release or extended-release. Official labeling does not generally specify a rule regarding morning or evening intake, but the prescribed schedule for the medicine should be adhered to.

Q: What are the signs of an allergic reaction to Ketoprofene EG?

A: Patients are advised by regulatory bodies of the potential for serious allergic reactions. Signs include difficulty breathing or swelling of the face or throat, and seeking emergency medical assistance is necessary if these signs appear.

Q: What are Ketoprofene EG’s uses according to the official product leaflet?

A: Regulatory documents state that the oral forms are indicated for the management of the signs and symptoms of several conditions. These uses include rheumatoid arthritis, osteoarthritis, mild to moderate pain, and menstrual cramps.

Q: What is the difference between Ketoprofene and Ketoprofene EG?

A: Ketoprofen is the chemical name for the active ingredient contained in the medicine. Ketoprofene EG is a specific pharmaceutical product that contains this active ingredient.

Q: Can taking Ketoprofene EG affect my ability to drive?

A: The medication is associated with common side effects such as dizziness and headache. Regulatory information indicates that these effects may potentially affect the ability to drive or operate machinery.

Q: How long do the effects of Ketoprofene EG usually last?

A: The active ingredient, Ketoprofen, has a short duration of action. The plasma half-life (which reflects how quickly the drug is eliminated) is typically described as being between one and three hours for the oral form.

Q: Can Ketoprofene EG be crushed or split before taking?

A: Official instructions for certain oral tablets and capsules state that the medicine should be swallowed whole. These forms should not be split, crushed, or chewed to ensure it works as intended.

Q: Are there different strengths available for Ketoprofene EG?

A: Yes, regulatory documents indicate that the active ingredient is supplied in various strengths. Oral forms are commonly available as 25 mg, 50 mg, 75 mg, and 200 mg capsules or tablets.

Q: Is there an interaction between Ketoprofene EG and alcohol?

A: Regulatory warnings indicate that consuming alcohol while taking this medication increases the risk of serious gastrointestinal side effects. This risk is related to serious conditions such as stomach bleeding.

Q: Are there certain foods or drinks to avoid while using Ketoprofene EG?

A: While the medicine can be taken with food, some patient information leaflets advise caution with high intake of coffee and spicy foods due to the potential for increased gastrointestinal irritation.

Q: Is Ketoprofene EG considered an opioid?

A: No. Ketoprofene EG is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It works differently from opioids and is not listed as a controlled substance in the official DEA/FDA schedules.

Q: Is Ketoprofene EG available without a prescription?

A: The legal status of the medicine depends on the country and the formulation. Some countries classify certain strengths or forms as prescription-only (Rx), while lower-strength topical or oral forms may be available over-the-counter (OTC).

Q: What is the potential for dependence or addiction with Ketoprofene EG?

A: Since Ketoprofene EG is classified as an NSAID and is not listed in the controlled substance schedules, regulatory bodies do not associate it with the risks of dependence or addiction.

Q: Is there a generic version of Ketoprofene EG available?

A: Yes. Regulatory documents indicate that the active ingredient, Ketoprofen, is widely available in generic versions that are approved for use.

Q: Does Ketoprofene EG contain gluten or lactose?

A: Official drug labeling for certain oral formulations of the immediate-release capsules confirms that the inactive ingredients include lactose monohydrate. Information regarding gluten is not explicitly provided across all standard drug labeling.

Q: Can Ketoprofene EG cause skin sensitivity to the sun?

A: Regulatory authorities have noted that the medication, particularly the topical gel/cream forms, may cause photosensitivity reactions. This means it can increase skin sensitivity to sunlight or other UV light sources.

Q: Can Ketoprofene EG affect fertility in men or women?

A: Regulatory information advises that, like other NSAIDs, the use of this drug may impair female fertility. Use is generally not advised for women who are planning or attempting to conceive.

Q: Does Ketoprofene EG interact with herbal supplements?

A: Patient information generally advises informing a doctor or pharmacist about all medicines, vitamins, and herbal supplements being used. This is a common precaution due to the potential for unknown interaction risks.

Q: Does Ketoprofene EG contain any substances listed as controlled?

A: No. The medicine is classified as an NSAID and is not included in the Drug Enforcement Administration (DEA) schedule of controlled substances. This means it is not regulated for potential misuse or diversion.

How to Store and Dispose of Ketoprofene EG

The storage and disposal procedures for Ketoprofene EG (Ketoprofen) are strictly defined by regulatory labeling to ensure product quality and public safety.

Requirement Type	Official Regulatory Statement
Storage Temperature	Store at Controlled Room Temperature, between 20^circC and 25^circC (68^circF and 77^circF).
Protection & Handling	Keep the medicine out of the reach and sight of children. Store it in its tightly closed container, away from moisture, direct light, and extreme heat. It must not be frozen.
Outdated Product	Do not keep medicine that is outdated or no longer needed.
Disposal Instructions	The preferred method for disposal is using an official drug take-back program. If one is unavailable, dispose of the medicine by mixing it with an undesirable substance (e.g., used coffee grounds, dirt) and placing it in a sealed container before discarding in the household trash. Do not dispose of unused product via wastewater or regular household garbage, except where explicitly advised by a pharmacist, and follow local requirements for unused medicinal products.